Peptidi

[Glu2]-TRH tripeptide – pGlu-Glu-Pro-NH2 (CAS: 85541-78-2)

A synthetic peptide for use as a blocking control in assays to test for specificity of WDR66 antibody, catalog no. 70R-3677

A synthetic peptide for use as a blocking control in assays to test for specificity of Twf1 antibody, catalog no. 70R-9403

The SPP1 Blocking Peptide is an activated peptide that falls under the category of Blocking Peptides. It acts as a growth factor and helps regulate the density of low-density lipoproteins in the body. Additionally, it has been shown to reduce cortisol concentration levels and inhibit the binding of vitronectin to certain receptors. The SPP1 Blocking Peptide can be used in various applications such as monoclonal antibody production, electrode coating, and as inhibitors for cortisol or steroid-related experiments. It finds wide usage in the field of Life Sciences and can be combined with other active agents like trastuzumab or other antibodies for enhanced effects.

Primary SIL peptide for Emicizumab  detection and quantification

A synthetic peptide for use as a blocking control in assays to test for specificity of PRR11 antibody, catalog no. 70R-3162

A synthetic peptide for use as a blocking control in assays to test for specificity of HSP90B1 antibody, catalog no. 70R-1478

SARS-CoV-2 Spike RBM 450-473 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Motif (RBM). SARS-CoV-2 Spike RBM 450-473 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBM:
The receptor-binding domain in SARS-CoV-2 Spike protein contains a receptor-binding motif RBM. SARS-CoV-2 Spike RBM is the main functional motif in RBD and allows contacts between the S protein and the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.
SB-PEPTIDE also offers SARS-CoV-2 Spike RBM 450-473 (Biotin-LC) peptide

PC Biotin Alkyne probes eliminate a major limitation of the streptavidin-biotin affinity purification. This reagent contains a biotin moiety linked to an azide moiety through a spacer arm containing a photocleavable linker. Captured biomolecules can be efficiently released under mild, reagent-free conditions (irradiation with near-UV, low intensity lamp) and the small molecular fragment (55.07 Da) left on the labelled protein following cleavage. These features make the photocleavable probe especially attractive for use in biomolecular labelling and proteomic studies.

A synthetic peptide for use as a blocking control in assays to test for specificity of RANBP3 antibody, catalog no. 70R-5726

A synthetic peptide for use as a blocking control in assays to test for specificity of NEXN antibody, catalog no. 70R-2949

A synthetic peptide for use as a blocking control in assays to test for specificity of UNC5C antibody, catalog no. 70R-7136

A synthetic peptide for use as a blocking control in assays to test for specificity of MYPN antibody, catalog no. 70R-10045

A synthetic peptide for use as a blocking control in assays to test for specificity of C20ORF20 antibody, catalog no. 70R-3421

A synthetic peptide for use as a blocking control in assays to test for specificity of RGS4 antibody, catalog no. 70R-5834

A synthetic peptide for use as a blocking control in assays to test for specificity of MUC12 antibody, catalog no. 70R-6626

A synthetic peptide for use as a blocking control in assays to test for specificity of RNF186 antibody, catalog no. 70R-6682

FRET-25Asp is a peptide that can be used in research as an activator, antibody, and inhibitor. It is used as a tool to study protein interactions with the cell membrane and ion channels. FRET-25Asp has also been shown to inhibit the activity of some receptors and ligands.